333 related articles for article (PubMed ID: 17721243)
21. Reduced effect of propofol at human {alpha}1{beta}2(N289M){gamma}2 and {alpha}2{beta}3(N290M){gamma}2 mutant GABA(A) receptors.
Jonsson Fagerlund M; Sjödin J; Krupp J; Dabrowski MA
Br J Anaesth; 2010 Apr; 104(4):472-81. PubMed ID: 20179014
[TBL] [Abstract][Full Text] [Related]
22. The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits.
Nishikawa K; Harrison NL
Anesthesiology; 2003 Sep; 99(3):678-84. PubMed ID: 12960553
[TBL] [Abstract][Full Text] [Related]
23. R (+) etomidate and the photoactivable R (+) azietomidate have comparable anesthetic activity in wild-type mice and comparably decreased activity in mice with a N265M point mutation in the gamma-aminobutyric acid receptor beta3 subunit.
Liao M; Sonner JM; Husain SS; Miller KW; Jurd R; Rudolph U; Eger EI
Anesth Analg; 2005 Jul; 101(1):131-5, table of contents. PubMed ID: 15976219
[TBL] [Abstract][Full Text] [Related]
24. A single M1 residue in the beta2 subunit alters channel gating of GABAA receptor in anesthetic modulation and direct activation.
Chang CS; Olcese R; Olsen RW
J Biol Chem; 2003 Oct; 278(44):42821-8. PubMed ID: 12939268
[TBL] [Abstract][Full Text] [Related]
25. Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital.
Maldifassi MC; Baur R; Sigel E
Neuropharmacology; 2016 Jun; 105():207-214. PubMed ID: 26767954
[TBL] [Abstract][Full Text] [Related]
26. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility.
Krasowski MD; Jenkins A; Flood P; Kung AY; Hopfinger AJ; Harrison NL
J Pharmacol Exp Ther; 2001 Apr; 297(1):338-51. PubMed ID: 11259561
[TBL] [Abstract][Full Text] [Related]
27. Mutations at beta N265 in γ-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics.
Stewart DS; Pierce DW; Hotta M; Stern AT; Forman SA
PLoS One; 2014; 9(10):e111470. PubMed ID: 25347186
[TBL] [Abstract][Full Text] [Related]
28. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.
Jurd R; Arras M; Lambert S; Drexler B; Siegwart R; Crestani F; Zaugg M; Vogt KE; Ledermann B; Antkowiak B; Rudolph U
FASEB J; 2003 Feb; 17(2):250-2. PubMed ID: 12475885
[TBL] [Abstract][Full Text] [Related]
29. The effect of propofol on actin, ERK-1/2 and GABAA receptor content in neurones.
Oscarsson A; Juhas M; Sjölander A; Eintrei C
Acta Anaesthesiol Scand; 2007 Oct; 51(9):1184-9. PubMed ID: 17850559
[TBL] [Abstract][Full Text] [Related]
30. Modulation of presynaptic beta3-containing GABAA receptors limits the immobilizing actions of GABAergic anesthetics.
Grasshoff C; Jurd R; Rudolph U; Antkowiak B
Mol Pharmacol; 2007 Sep; 72(3):780-7. PubMed ID: 17584992
[TBL] [Abstract][Full Text] [Related]
31. Trichloroethanol modulation of recombinant GABAA, glycine and GABA rho 1 receptors.
Krasowski MD; Finn SE; Ye Q; Harrison NL
J Pharmacol Exp Ther; 1998 Mar; 284(3):934-42. PubMed ID: 9495852
[TBL] [Abstract][Full Text] [Related]
32. Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit.
Davies PA; Hanna MC; Hales TG; Kirkness EF
Nature; 1997 Feb; 385(6619):820-3. PubMed ID: 9039914
[TBL] [Abstract][Full Text] [Related]
33. Anaesthetic binding sites for etomidate and propofol on a GABAA receptor model.
Campagna-Slater V; Weaver DF
Neurosci Lett; 2007 May; 418(1):28-33. PubMed ID: 17412502
[TBL] [Abstract][Full Text] [Related]
34. Pregnenolone sulphate and Zn2+ inhibit recombinant rat GABA(A) receptor through different channel property.
Wang MD; Rahman M; Zhu D; Bäckström T
Acta Physiol (Oxf); 2006; 188(3-4):153-62. PubMed ID: 17054655
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of molecular requirements for the actions of general anaesthetics at the gamma-aminobutyric acidA receptor subtype, alpha1beta2gamma2.
Siegwart R; Krähenbühl K; Lambert S; Rudolph U
BMC Pharmacol; 2003 Nov; 3():13. PubMed ID: 14613517
[TBL] [Abstract][Full Text] [Related]
36. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives.
Barann M; Linden I; Witten S; Urban BW
Anesth Analg; 2008 Mar; 106(3):846-57, table of contents. PubMed ID: 18292429
[TBL] [Abstract][Full Text] [Related]
37. Defining the propofol binding site location on the GABAA receptor.
Bali M; Akabas MH
Mol Pharmacol; 2004 Jan; 65(1):68-76. PubMed ID: 14722238
[TBL] [Abstract][Full Text] [Related]
38. Potentiation, activation and blockade of GABAA receptors by etomidate in the rat sacral dorsal commissural neurons.
Hong Z; Wang DS
Neuroscience; 2005; 132(4):1045-53. PubMed ID: 15857709
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis for modulation of recombinant alpha1beta2gamma2 GABAA receptors by protons.
Huang RQ; Chen Z; Dillon GH
J Neurophysiol; 2004 Aug; 92(2):883-94. PubMed ID: 15028749
[TBL] [Abstract][Full Text] [Related]
40. Etomidate and other non-barbiturates.
Vanlersberghe C; Camu F
Handb Exp Pharmacol; 2008; (182):267-82. PubMed ID: 18175096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
